Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Helicobacter pylori 50S ribosomal subunit is the larger component of the bacterial 70S ribosome, playing a fundamental role in protein biosynthesis (UniProt). It is composed of 23S and 5S ribosomal RNA (rRNA) molecules along with approximately 33 ribosomal proteins (PubMed). The subunit contains the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds, and the polypeptide exit tunnel through which the growing protein chain leaves the ribosome (StatPearls). This subunit is a primary target for several classes of antibiotics, including macrolides, lincosamides, and oxazolidinones (PubChem). In the context of H. pylori, macrolides like clarithromycin bind to the 23S rRNA to inhibit translation, making it a critical target for treating infections linked to gastritis, peptic ulcers, and gastric adenocarcinoma (NIH). However, the emergence of point mutations in the 23S rRNA has led to increasing rates of antibiotic resistance, complicating clinical management (PubMed). Monitoring these genetic biomarkers is increasingly important for tailoring antibiotic treatment to individual patients.
Inhibition of bacterial protein synthesis by binding to the 23S rRNA of the 50S subunit, which prevents peptidyl transfer or blocks the ribosomal exit tunnel, thereby halting the elongation of the polypeptide chain (StatPearls, PubMed).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori 50S ribosomal subunit (50S subunit).